HK1172023A1 - Pyrazine derivatives and their use in the treatment of neurological disorders - Google Patents
Pyrazine derivatives and their use in the treatment of neurological disordersInfo
- Publication number
- HK1172023A1 HK1172023A1 HK12112853A HK12112853A HK1172023A1 HK 1172023 A1 HK1172023 A1 HK 1172023A1 HK 12112853 A HK12112853 A HK 12112853A HK 12112853 A HK12112853 A HK 12112853A HK 1172023 A1 HK1172023 A1 HK 1172023A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- neurological disorders
- pyrazine derivatives
- pyrazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29172409P | 2009-12-31 | 2009-12-31 | |
PCT/EP2010/070502 WO2011080176A1 (en) | 2009-12-31 | 2010-12-22 | Pyrazine derivatives and their use in the treatment of neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1172023A1 true HK1172023A1 (en) | 2013-04-12 |
Family
ID=43598456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12112853A HK1172023A1 (en) | 2009-12-31 | 2012-12-12 | Pyrazine derivatives and their use in the treatment of neurological disorders |
Country Status (27)
Country | Link |
---|---|
US (2) | US20120277244A1 (xx) |
EP (1) | EP2519515B1 (xx) |
JP (1) | JP5600754B2 (xx) |
KR (1) | KR101419157B1 (xx) |
CN (1) | CN102712621B (xx) |
AU (1) | AU2010338365B2 (xx) |
BR (1) | BR112012015916A2 (xx) |
CA (1) | CA2785341A1 (xx) |
CL (1) | CL2012001762A1 (xx) |
CR (1) | CR20120332A (xx) |
CU (1) | CU20120099A7 (xx) |
EA (1) | EA201200952A1 (xx) |
EC (1) | ECSP12012065A (xx) |
ES (1) | ES2445536T3 (xx) |
GT (1) | GT201200219A (xx) |
HK (1) | HK1172023A1 (xx) |
HN (1) | HN2012001413A (xx) |
IL (1) | IL220268A0 (xx) |
MX (1) | MX2012007754A (xx) |
NZ (1) | NZ600136A (xx) |
PE (1) | PE20121640A1 (xx) |
PL (1) | PL2519515T3 (xx) |
PT (1) | PT2519515E (xx) |
SG (1) | SG181431A1 (xx) |
TN (1) | TN2012000249A1 (xx) |
WO (1) | WO2011080176A1 (xx) |
ZA (1) | ZA201203614B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103936690B (zh) | 2005-10-25 | 2016-06-08 | 盐野义制药株式会社 | 氨基二氢噻嗪衍生物 |
EP2151435A4 (en) | 2007-04-24 | 2011-09-14 | Shionogi & Co | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
CA2683887A1 (en) | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivatives substituted with a cyclic group having inhibitory activity against production of amyloid beta protein |
ES2738123T3 (es) | 2008-06-13 | 2020-01-20 | Shionogi & Co | Derivado heterocíclico que contiene azufre que tiene actividad inhibitoria de ß-secretasa |
US8703785B2 (en) | 2008-10-22 | 2014-04-22 | Shionogi & Co., Ltd. | 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
MX2012006491A (es) | 2009-12-11 | 2012-07-03 | Shionogi & Co | Derivados de oxazina. |
SG185652A1 (en) * | 2010-06-09 | 2012-12-28 | Janssen Pharmaceutica Nv | 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
CN102933564B (zh) | 2010-06-09 | 2015-07-22 | 詹森药业有限公司 | 用作β-分泌酶(BACE)抑制剂的5,6-二氢-2H-[1,4]噁嗪-3-基-胺衍生物 |
CN102985412A (zh) * | 2010-06-28 | 2013-03-20 | 詹森药业有限公司 | 可用于治疗阿尔茨海默病及其它形式的痴呆的3-氨基-5,6-二氢-1h-吡嗪-2-酮衍生物 |
AU2011321427A1 (en) | 2010-10-29 | 2013-05-02 | Shionogi & Co., Ltd. | Naphthyridine derivative |
EP2634188A4 (en) | 2010-10-29 | 2014-05-07 | Shionogi & Co | FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE |
BR112013015430A2 (pt) | 2010-12-22 | 2016-09-20 | Janssen Pharmaceutica Nv | derivados de 5,6-diidro-imidazo[1,2-a]pirazin-8-ilamina úteis como inibidores de beta-secretase (bace) |
US8524897B2 (en) | 2011-01-12 | 2013-09-03 | Novartis Ag | Crystalline oxazine derivative |
MX2013008192A (es) * | 2011-01-13 | 2013-12-16 | Novartis Ag | Inhibidores de bace-2 para tratamiento de transtornos metabolicos. |
AP3807A (en) | 2011-01-13 | 2016-09-30 | Novartis Ag | Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
WO2012117027A1 (en) | 2011-03-01 | 2012-09-07 | Janssen Pharmaceutica Nv | 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
ES2534973T3 (es) | 2011-03-09 | 2015-04-30 | Janssen Pharmaceutica N.V. | Derivados de 3,4-dihidro-pirrolo[1,2-a]pirazin-1-ilamina útiles como inhibidores de beta-secretasa (BACE) |
EP2694489B1 (en) | 2011-04-07 | 2017-09-06 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
US9145426B2 (en) | 2011-04-07 | 2015-09-29 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
JP2014514302A (ja) | 2011-04-13 | 2014-06-19 | メルク・シャープ・アンド・ドーム・コーポレーション | Bace阻害薬としての5−置換されたイミノチアジン類およびそれのモノおよびジオキシド、組成物およびそれらの使用 |
US8883779B2 (en) | 2011-04-26 | 2014-11-11 | Shinogi & Co., Ltd. | Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them |
KR20140054295A (ko) | 2011-08-22 | 2014-05-08 | 머크 샤프 앤드 돔 코포레이션 | Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도 |
US8338413B1 (en) | 2012-03-07 | 2012-12-25 | Novartis Ag | Oxazine derivatives and their use in the treatment of neurological disorders |
WO2014065434A1 (en) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity |
WO2014099794A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | C5, c6 oxacyclic-fused iminothiazine dioxide compounds as bace inhibitors |
ES2721073T3 (es) | 2013-06-12 | 2019-07-26 | Janssen Pharmaceutica Nv | Derivados de 4-amino-6-fenil-6,7-dihidro[1,2,3]triazolo[1,5 a]pirazina como inhibidores de beta-secretasa (BACE) |
JP6387402B2 (ja) | 2013-06-12 | 2018-09-05 | ヤンセン ファーマシューティカ エヌ.ベー. | β−セクレターゼ(BACE)の阻害剤としての4−アミノ−6−フェニル−5,6−ジヒドロイミダゾ[1,5−A]ピラジン−3(2H)−オン誘導体 |
MX369629B (es) | 2013-06-12 | 2019-11-14 | Janssen Pharmaceutica Nv | Derivados de 4-a mino-6-fenil-5,6-dihidroimidazo[1,5 a]pirazina como inhibidores de beta-secretasa (bace). |
WO2016096979A1 (en) | 2014-12-18 | 2016-06-23 | Janssen Pharmaceutica Nv | 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase |
CN107011134B (zh) * | 2017-04-28 | 2021-02-05 | 浙江中欣氟材股份有限公司 | 一种2-氟-5-溴苯乙酮的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6911868A (xx) | 1968-08-31 | 1970-03-03 | ||
AUPQ319899A0 (en) * | 1999-10-01 | 1999-10-28 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds |
EP1363702A4 (en) * | 2001-01-30 | 2007-08-22 | Cytopia Pty Ltd | PROCESS FOR INHIBITING KINASES |
JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
EP1702919B1 (en) | 2003-12-29 | 2012-05-30 | Msd K.K. | Novel 2-heteroaryl-substituted benzimidazole derivative |
US20050215884A1 (en) * | 2004-02-27 | 2005-09-29 | Greicius Michael D | Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI |
CN103936690B (zh) * | 2005-10-25 | 2016-06-08 | 盐野义制药株式会社 | 氨基二氢噻嗪衍生物 |
CN102775396B (zh) * | 2005-11-08 | 2014-10-08 | 沃泰克斯药物股份有限公司 | Atp-结合弹夹转运蛋白的杂环调控剂 |
JP2010514689A (ja) * | 2006-12-22 | 2010-05-06 | ノバルティス アーゲー | 癌、炎症およびウイルス感染症の処置のためのcdk阻害剤としてのヘテロアリール−ヘテロアリール化合物 |
UA101352C2 (xx) | 2008-01-18 | 2013-03-25 | Ейсей Р Енд Д Менеджмент Ко., Лтд. | Конденсоване похідне амінодигідротіазину$конденсированная производная аминодигидротиазина |
US8703785B2 (en) | 2008-10-22 | 2014-04-22 | Shionogi & Co., Ltd. | 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
UY32799A (es) * | 2009-07-24 | 2011-02-28 | Novartis Ag | Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos |
SG185652A1 (en) * | 2010-06-09 | 2012-12-28 | Janssen Pharmaceutica Nv | 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
CN102985412A (zh) * | 2010-06-28 | 2013-03-20 | 詹森药业有限公司 | 可用于治疗阿尔茨海默病及其它形式的痴呆的3-氨基-5,6-二氢-1h-吡嗪-2-酮衍生物 |
-
2010
- 2010-12-22 CA CA 2785341 patent/CA2785341A1/en not_active Abandoned
- 2010-12-22 PE PE2012000897A patent/PE20121640A1/es not_active Application Discontinuation
- 2010-12-22 MX MX2012007754A patent/MX2012007754A/es active IP Right Grant
- 2010-12-22 KR KR1020127019872A patent/KR101419157B1/ko not_active IP Right Cessation
- 2010-12-22 CN CN201080060047.7A patent/CN102712621B/zh not_active Expired - Fee Related
- 2010-12-22 NZ NZ60013610A patent/NZ600136A/xx not_active IP Right Cessation
- 2010-12-22 BR BR112012015916A patent/BR112012015916A2/pt not_active IP Right Cessation
- 2010-12-22 US US13/518,907 patent/US20120277244A1/en not_active Abandoned
- 2010-12-22 WO PCT/EP2010/070502 patent/WO2011080176A1/en active Application Filing
- 2010-12-22 PL PL10796064T patent/PL2519515T3/pl unknown
- 2010-12-22 SG SG2012036935A patent/SG181431A1/en unknown
- 2010-12-22 JP JP2012546418A patent/JP5600754B2/ja not_active Expired - Fee Related
- 2010-12-22 ES ES10796064T patent/ES2445536T3/es active Active
- 2010-12-22 AU AU2010338365A patent/AU2010338365B2/en not_active Ceased
- 2010-12-22 PT PT10796064T patent/PT2519515E/pt unknown
- 2010-12-22 EA EA201200952A patent/EA201200952A1/ru unknown
- 2010-12-22 EP EP20100796064 patent/EP2519515B1/en active Active
-
2012
- 2012-05-17 ZA ZA2012/03614A patent/ZA201203614B/en unknown
- 2012-05-22 TN TNP2012000249A patent/TN2012000249A1/en unknown
- 2012-06-07 IL IL220268A patent/IL220268A0/en unknown
- 2012-06-19 CR CR20120332A patent/CR20120332A/es unknown
- 2012-06-25 CU CU20120099A patent/CU20120099A7/es unknown
- 2012-06-27 CL CL2012001762A patent/CL2012001762A1/es unknown
- 2012-06-28 GT GT201200219A patent/GT201200219A/es unknown
- 2012-06-28 HN HN2012001413A patent/HN2012001413A/es unknown
- 2012-07-25 EC ECSP12012065 patent/ECSP12012065A/es unknown
- 2012-12-12 HK HK12112853A patent/HK1172023A1/xx not_active IP Right Cessation
-
2015
- 2015-07-21 US US14/805,446 patent/US20150322038A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102712621A (zh) | 2012-10-03 |
TN2012000249A1 (en) | 2013-12-12 |
AU2010338365B2 (en) | 2014-01-30 |
CU20120099A7 (es) | 2012-07-31 |
MX2012007754A (es) | 2012-08-01 |
PE20121640A1 (es) | 2012-12-17 |
US20150322038A1 (en) | 2015-11-12 |
BR112012015916A2 (pt) | 2017-04-25 |
EP2519515A1 (en) | 2012-11-07 |
ZA201203614B (en) | 2013-01-30 |
EA201200952A1 (ru) | 2013-02-28 |
PT2519515E (pt) | 2014-02-17 |
CN102712621B (zh) | 2015-03-11 |
ES2445536T3 (es) | 2014-03-03 |
CL2012001762A1 (es) | 2012-12-21 |
KR101419157B1 (ko) | 2014-07-11 |
HN2012001413A (es) | 2015-03-23 |
PL2519515T3 (pl) | 2014-04-30 |
CA2785341A1 (en) | 2011-07-07 |
NZ600136A (en) | 2013-09-27 |
KR20120102795A (ko) | 2012-09-18 |
IL220268A0 (en) | 2012-07-31 |
US20120277244A1 (en) | 2012-11-01 |
CR20120332A (es) | 2012-07-12 |
EP2519515B1 (en) | 2013-11-06 |
WO2011080176A1 (en) | 2011-07-07 |
GT201200219A (es) | 2013-10-10 |
JP5600754B2 (ja) | 2014-10-01 |
SG181431A1 (en) | 2012-07-30 |
JP2013516395A (ja) | 2013-05-13 |
ECSP12012065A (es) | 2012-08-31 |
AU2010338365A1 (en) | 2012-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1172023A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
HK1168091A1 (en) | Oxazine derivatives and their use in the treatment of neurological disorders | |
AP3807A (en) | Novel heterocyclic derivatives and their use in the treatment of neurological disorders | |
ZA201109384B (en) | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases | |
ZA201100482B (en) | Pyrazolopyrimidines and their use for the treatment of cns disorders | |
IL205108A0 (en) | Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders | |
HK1170485A1 (zh) | -噻唑烷- -酮衍生物及其在癌症治療中的用途 | |
EP2268140A4 (en) | NOVEL COMPOUNDS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
EP2278972A4 (en) | TREATMENT FOR NEUROLOGICAL AND MENTAL DISORDERS | |
EP2393945A4 (en) | DOUBLE TARGETING OF MIR-208 AND MIR-499 IN THE TREATMENT OF CARDIAC DISORDERS | |
GB0904044D0 (en) | The treatment of inflammatory disorders and pain | |
ZA201108106B (en) | Use of phthalimide derivatives in the treatment of diseases | |
IL209417A0 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders | |
GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
HK1145282A1 (en) | Treatment of sleep disorders | |
GB0814043D0 (en) | The treatment of skin disorders | |
TH134234B (th) | สารอนุพันธ์ไพราซีน (Pyrazine derivatives) และ การใช้ของสารนั้นในการบำบัด ของความผิกปกติทางประสาท | |
GB0817330D0 (en) | The treatment of inflammatory disorders and pain | |
GB0803397D0 (en) | The treatment of inflammatory disorders and pain | |
GB0703494D0 (en) | The treatment of inflammatory disorders and pain | |
GB0718279D0 (en) | The treatment of inflammatory disorders and pain | |
GB0711769D0 (en) | The treatment of inflammatory disorders and pain | |
GB0722524D0 (en) | The treatment of inflammatory disorders and pain | |
AU2010901520A0 (en) | Substituted thienobenzodiazepines and their use in the treatment of CNS disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171222 |